Chemoinformaics analysis of EUPHORBADIENOL
Molecular Weight | 440.756 | nRot | 5 |
Heavy Atom Molecular Weight | 388.34 | nRig | 21 |
Exact Molecular Weight | 440.402 | nRing | 4 |
Solubility: LogS | -5.832 | nHRing | 0 |
Solubility: LogP | 7.284 | No. of Aliphatic Rings | 4 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
Atoms Count | 84 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 2 |
No. of Hydrogen atom | 52 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 31 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 87.2452 |
nHD | 1 | BPOL | 52.1668 |
QED | 0.424 |
Synth | 4.652 |
Natural Product Likeliness | 3.383 |
NR-PPAR-gamma | 0.292 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.961 |
Pgp-sub | 0 |
HIA | 0.009 |
CACO-2 | -4.928 |
MDCK | 0.00000944 |
BBB | 0.188 |
PPB | 0.968621 |
VDSS | 2.126 |
FU | 0.0166827 |
CYP1A2-inh | 0.026 |
CYP1A2-sub | 0.578 |
CYP2c19-inh | 0.069 |
CYP2c19-sub | 0.98 |
CYP2c9-inh | 0.106 |
CYP2c9-sub | 0.561 |
CYP2d6-inh | 0.038 |
CYP2d6-sub | 0.865 |
CYP3a4-inh | 0.378 |
CYP3a4-sub | 0.853 |
CL | 10.911 |
T12 | 0.006 |
hERG | 0.006 |
Ames | 0.024 |
ROA | 0.091 |
SkinSen | 0.048 |
Carcinogencity | 0.017 |
EI | 0.304 |
Respiratory | 0.616 |
NR-Aromatase | 0.314 |
Antiviral | No |
Prediction | 0.554195 |